Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Immunic reported $766K in Interest Income for its fiscal quarter ending in September of 2023.

Interest Income Change Date
BioMarin Pharmaceutical USD 15.74M 3.13M Sep/2023
CSL USD 3.3M 31.4M Jun/2023
Dynavax Technologies USD 8.46M 1.08M Sep/2023
Immunic USD 766K 202K Sep/2023
Insmed 666K 312K Sep/2023
Quidel 1.3M 500K Sep/2023
Revance Therapeutics USD 3.73M 585K Sep/2023
Ultragenyx Pharmaceutical USD 5.88M 83K Sep/2023
United Therapeutics USD 45.3M 8.1M Sep/2023